The occurrence of hyperaldosteronism in infants with congestive heart failure.
Serum aldosterone and plasma renin were measured in 20 normal infants and 15 infants with congestive cardiac failure. Serum aldosterone was significantly increased (151 +/- 38 ng/dl mean +/- standard error of the mean) in patients before treatment when compared with aldosterone in normal infants (29 +/- 7 ng/dl). Increasing serum aldosterone was related to increasing plasma renin. The response to furosemide appeared to be inversely related to serum aldosterone concentrations. In four infants, administration of an aldosterone antagonist (spironolactone) resulted in improved diuresis and decreased serum aldosterone. Hyperaldosteronism is an important factor contributing to fluid and sodium retention in infants with heart failure.
D000450:Aldosterone / Q000097:blood; D001835:Body Weight; D004812:Epidemiologic Methods; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications* / Q000188:drug therapy; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009994:Osmolar Concentration; D011188:Potassium / Q000097:blood / Q000652:urine; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood / Q000652:urine; D013148:Spironolactone / Q000627:therapeutic use
D013148:Spironolactone; D000450:Aldosterone; D005665:Furosemide; D012964:Sodium; D012083:Renin; D011188:Potassium